comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Glucagon-Like Peptide-1 Receptor in Patients With Type 2 Diabetes GLP-1 Agonists in Cardiovascular Diseases:

If you're more than two days off schedule, contact your PlexusDx provider for guidance on how to resume your regular cycle without creating overlap or gaps in medication coverage

Many people with Hashimotos find weight loss very difficult, and these medications can be a helpful tool

they are powerful hormonal agents that fundamentally alter the communication between your gut and your brain

Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jdar E, Kandler K, Rigas G, Wadden TA, Wharton S, STEP 5 Study Group (2022) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Locus 9q34.2, which encompasses the ABO gene previously established in both ovarian cancer and diabetes, exhibited particularly broad pleiotropy, associating with ten GLP-1R agonist-related traits including type 2 diabetes, lipid parameters, and blood pressure